Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials
A Messori, S Trippoli - Journal of Chemotherapy, 2023 - Taylor & Francis
In inoperable pleural mesothelioma, pemetrexed+ cisplatin as first line is considered the
standard of care, but novel treatments have been recently proposed. Our objective was to …
standard of care, but novel treatments have been recently proposed. Our objective was to …
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials.
A Messori, S Trippoli - Journal of Chemotherapy (Florence, Italy), 2022 - europepmc.org
In inoperable pleural mesothelioma, pemetrexed+ cisplatin as first line is considered the
standard of care, but novel treatments have been recently proposed. Our objective was to …
standard of care, but novel treatments have been recently proposed. Our objective was to …
Current treatments for inoperable mesothelioma: indirect comparisons based on individual patient data reconstructed retrospectively from 4 trials
A Messori, S Trippoli - Journal of chemotherapy (Florence …, 2023 - pubmed.ncbi.nlm.nih.gov
In inoperable pleural mesothelioma, pemetrexed+ cisplatin as first line is considered the
standard of care, but novel treatments have been recently proposed. Our objective was to …
standard of care, but novel treatments have been recently proposed. Our objective was to …